[fcb5af]: / literature / by_gene_clean / SETD2.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34977845 10.1016/j.xjidi.2021.100068 2022 Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders. SETD2
2 35030632 10.1182/bloodadvances.2021006410 2022 Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. SETD2
3 35522148 10.3324/haematol.2021.280005 2022 Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase <i>KDM4C</i> in B cell lymphomas. SETD2
4 35726023 10.1038/s41684-022-00998-x 2022 The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications. SETD2
5 35895386 10.1111/bjd.21791 2022 Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. SETD2
6 31028364 10.1038/s41379-019-0279-8 2020 Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. SETD2
7 32469082 10.1002/cncr.32866 2020 Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. SETD2
8 32695399 10.1186/s40364-020-00205-4 2020 Plasma circulating tumor DNA assessment reveals <i>KMT2D</i> as a potential poor prognostic factor in extranodal NK/T-cell lymphoma. SETD2
9 30307363 10.1080/15384047.2018.1523857 2019 Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL). SETD2
10 31221981 10.1038/s12276-019-0230-6 2019 The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. SETD2
11 29305415 10.3324/haematol.2017.182444 2018 Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. SETD2
12 28122867 10.1158/2159-8290.CD-16-0330 2017 The Genetic Basis of Hepatosplenic T-cell Lymphoma. SETD2
13 27505670 10.1016/j.ccell.2016.07.006 2016 EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis. SETD2
14 27600764 10.1038/ncomms12602 2016 Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. SETD2